CIDP is an autoimmune disorder of the peripheral nerves. As its name implies, the disorder is chronic and long-term treatment (therapeutic dependance) may be frequently observed. The factors predicting such treatment dependence need to be elucidated in order to achieve a more appropriate patient management. In this issue of the journal, Rabin and colleagues identify the “treatment-dependent” and ” treatment withdrawal” groups establishing important clinical differences between the groups. Of relevance, therapy with IVIg seems to be associated with the former group while the latter groups was more response to steroids, suggesting differences in the underlying immunopathogenic processes.
Read more at: http://jnnp.bmj.com/content/85/8/901.abstract